about
The dominant role of IL-8 as an angiogenic driver in a three-dimensional physiological tumor construct for drug testing.Bevacizumab plus ipilimumab in patients with metastatic melanoma.Cabozantinib inhibits growth of androgen-sensitive and castration-resistant prostate cancer and affects bone remodelingThe biology of castration-resistant prostate cancerNovel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer.Apparent diffusion coefficients in prostate cancer: correlation with molecular markers Ki-67, HIF-1α and VEGF.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Bevacizumab treatment of prostate cancer.
@en
type
label
Bevacizumab treatment of prostate cancer.
@en
prefLabel
Bevacizumab treatment of prostate cancer.
@en
P2860
P1476
Bevacizumab treatment of prostate cancer.
@en
P2860
P304
P356
10.1517/14712598.2012.704015
P407
P577
2012-07-09T00:00:00Z